During the past decade, Lexington Pulmonary & Critical Care conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Lexington Pulmonary & Critical Care" are "Pulmonary Arterial Hypertension" (3 trials) and "Pulmonary Hypertension" (1 trials). Many other conditions were trialed in "Lexington Pulmonary & Critical Care" in a lesser frequency.

Most popular intervention types in "Lexington Pulmonary & Critical Care" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Ambrisentan" (1 trials), "iloprost" (1 trials), "iloprost (5 µg)" (1 trials), "inhaled prostacyclin" (1 trials) and "oral ERA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Lexington Pulmonary & Critical Care" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Lexington Pulmonary & Critical Care". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Lexington Pulmonary & Critical Care, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Lexington Pulmonary & Critical Care, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".